- Home
- OXSQ vs ACHV Comparison
OXSQ vs ACHV Comparison
Compare OXSQ & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- ACHV
- Stock Information
- Founded
- OXSQ 2003
- ACHV N/A
- Country
- OXSQ United States
- ACHV Canada
- Employees
- OXSQ N/A
- ACHV N/A
- Industry
- OXSQ Blank Checks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OXSQ Finance
- ACHV Health Care
- Exchange
- OXSQ Nasdaq
- ACHV Nasdaq
- Market Cap
- OXSQ 185.5M
- ACHV 159.0M
- IPO Year
- OXSQ N/A
- ACHV N/A
- Fundamental
- Price
- OXSQ $2.70
- ACHV $4.25
- Analyst Decision
- OXSQ
- ACHV Strong Buy
- Analyst Count
- OXSQ 0
- ACHV 5
- Target Price
- OXSQ N/A
- ACHV $14.80
- AVG Volume (30 Days)
- OXSQ 431.2K
- ACHV 112.1K
- Earning Date
- OXSQ 11-05-2024
- ACHV 11-07-2024
- Dividend Yield
- OXSQ 15.56%
- ACHV N/A
- EPS Growth
- OXSQ N/A
- ACHV N/A
- EPS
- OXSQ N/A
- ACHV N/A
- Revenue
- OXSQ $44,787,853.00
- ACHV N/A
- Revenue This Year
- OXSQ N/A
- ACHV N/A
- Revenue Next Year
- OXSQ N/A
- ACHV N/A
- P/E Ratio
- OXSQ N/A
- ACHV N/A
- Revenue Growth
- OXSQ N/A
- ACHV N/A
- 52 Week Low
- OXSQ $2.67
- ACHV $3.03
- 52 Week High
- OXSQ $3.29
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- OXSQ 24.79
- ACHV 35.58
- Support Level
- OXSQ $2.87
- ACHV $4.32
- Resistance Level
- OXSQ $2.96
- ACHV $4.75
- Average True Range (ATR)
- OXSQ 0.05
- ACHV 0.23
- MACD
- OXSQ -0.02
- ACHV -0.06
- Stochastic Oscillator
- OXSQ 10.31
- ACHV 9.40
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.